Renewable energy

Increasing incidences of cancer to fuel the global cancer immunotherapies market by 2020

  Cancer immunotherapies: Key market research findings Increase in the pervasiveness of cancer Strategic alliances between vendors Technavio has released a new market research report on the global cancer immunotherapies market, which is expected to grow at a CAGR of around 15% by 2020. The primary driver for the cancer immunotherapies market is the increasing…

Read More
Renewable energy

Technavio says global immunotherapy drugs market to surpass $197 billion by 2020

  Immunotherapy drugs: Key market research findings Growing significance and adoption of biosimilars Increase in demand for mAbs Technavio has released a new market research report on the global immunotherapy drugs market, which is expected to grow at a CAGR of around 12% between 2016 and 2020. The rising prevalence of cancer and autoimmune diseases…

Read More
Renewable energy

Global oncology biosimilars market set to grow at a CAGR of 32% by 2020, says Technavio

  This research report provides a segmentation of the global oncology biosimilars market by end-users (retail pharmacies and hospitals), by application (cancer treatment drugs and supportive care drugs) and by geography (EMEA, APAC and Americas). The leading vendors analyzed in this report are Biocon, Celltrion, Hospira, Mylan, Dr. Reddy’s Laboratories, Roche, and Sandoz. Technavio’s market…

Read More
Renewable energy

Technavio expects global cancer pain therapeutics market to reach over $7 billion by 2019

  Covering: This market research report from Technavio segments the global cancer pain therapeutics market by drug class (opioids, non-steroidal anti-inflammatory drugs, and others) and by geography (APAC, EMEA, and the Americas). Key vendors in this market are BioDelivery Sciences, ProStrakan Group, and Teva Pharmaceuticals. Technavio’s market research analysts estimate the global cancer pain therapeutics market,…

Read More
Renewable energy

Technavio expects global gastric cancer drugs market to surpass $2 billion by 2020

  This market research report includes a detailed segmentation of the global gastric cancer drugs market by molecule type (small molecules and biologics), by route of administration (oral and parenteral), by lines of chemotherapy (first-line chemotherapy and second-line chemotherapy), and by geography (APAC, Americas, and Europe). The key vendors analyzed in this report are Eli…

Read More
Renewable energy

Global drug device combination products market expected to surpass $15 billion by 2019, says Technavio

  Drug device combination products: Key market research findings Introduction of bioabsorbable stents Growing demand for drug-eluting stents Technavio has added a new market research report on the global drug device combination products market, to its drug delivery portfolio. The global drug device combination products market is expected to grow at a CAGR of 11%…

Read More
Renewable energy

Global acute lymphocytic leukemia market expected to reach over $3.620 million by 2019, says Technavio

  The new research report provides an in-depth study of the acute lymphocytic leukemia market and segmentation by route of administration (oral and parenteral), by type of molecules (biologics and small molecules), and by geography (the Americas, EMEA, and APAC). The report also presents a detailed analysis of the top companies operating in the market,…

Read More
Renewable energy

Global non-small cell lung cancer therapeutics market expected to exceed US $8 billion by 2019, says Technavio

  Non-small cell lung cancer therapeutics: Key market research findings Increased awareness towards cancer campaigns and promotion of patient assistance programs Entry of new drugs and therapies Technavio has added a new market research report on the global non-small cell lung cancer therapeutics market, to its lung cancer portfolio. Technavio’s market research analysts estimate the…

Read More
Renewable energy

Global head and neck cancer diagnostics market expected to reach over US $11 billion by 2019, says Technavio

  This new market analysis from Technavio segments the global head and neck cancer diagnostics market by different diagnostic methods such as diagnostic imaging, endoscopy, and dental diagnostics. Additionally, the market is classified into different geographies, including the Americas, EMEA, and the APAC region, and discusses the trending factors influencing their market shares. GE Healthcare,…

Read More
Renewable energy

Global HER2-Negative breast cancer market expected to generate around US $4 billion by 2019, says Technavio

  HER2-Breast Cancer: Kay market research findings Emerging new therapies and procedures Rise in public awareness and patient assistance programs Technavio has added a new market research report on the global HER2 negative breast cancer market, to its breast cancer portfolio. Technavio’s market research analysts estimate the HER2 negative breast cancer market to grow at…

Read More